Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Goldstein

Showing results (71-80 of 194) with videos related to

Pageof 20
Sort By:
The Lancet. Diabetes & Endocrinology|December 24, 2017
Questioning the safety and benefits of evolocumabLuca Mascitelli, Mark R Goldstein
Circulation|November 25, 2016
Letter by Mascitelli and Goldstein Regarding Article, "Is Statin Monotherapy the Perfect Polypill?"Luca Mascitelli, Mark R Goldstein
Diabetologia|January 30, 2017
PCSK9 inhibition and the global diabetes epidemicLuca Mascitelli, Mark R Goldstein
The New England Journal of Medicine|September 23, 2016
Blood-Pressure and Cholesterol Lowering in the HOPE-3 TrialLuca Mascitelli, Mark R Goldstein
Lancet (London, England)|May 17, 2011
Aspirin in the prevention of cancerLuca Mascitelli, Mark R Goldstein
International Journal of Cardiology|September 13, 2011
Statins, cholesterol depletion and risk of incident diabetesLuca Mascitelli, Mark R Goldstein
Lancet (London, England)|October 18, 2011
Benefits of lowering cholesterol in chronic kidney diseaseLuca Mascitelli, Mark R Goldstein
International Journal of Cardiology|November 11, 2011
Might diabetes-related increased iron stores erase the female advantage in the development of coronary heart disease?Luca Mascitelli, Mark R Goldstein
JAMA Cardiology|January 5, 2017
Effect of Iron Levels on Women After Premature or Early-Onset MenopauseLuca Mascitelli, Mark R Goldstein
Journal of the American College of Cardiology|January 1, 2016
Evaluating Statin Versus Statin Plus Ezetimibe for Coronary Plaque RegressionLuca Mascitelli, Mark R Goldstein
Pageof 20

Showing results (71-80 of 194) with videos related to

Sort By:
Pageof 20
The Lancet. Diabetes & Endocrinology|December 24, 2017
Questioning the safety and benefits of evolocumabLuca Mascitelli, Mark R Goldstein
Circulation|November 25, 2016
Letter by Mascitelli and Goldstein Regarding Article, "Is Statin Monotherapy the Perfect Polypill?"Luca Mascitelli, Mark R Goldstein
Diabetologia|January 30, 2017
PCSK9 inhibition and the global diabetes epidemicLuca Mascitelli, Mark R Goldstein
The New England Journal of Medicine|September 23, 2016
Blood-Pressure and Cholesterol Lowering in the HOPE-3 TrialLuca Mascitelli, Mark R Goldstein
Lancet (London, England)|May 17, 2011
Aspirin in the prevention of cancerLuca Mascitelli, Mark R Goldstein
International Journal of Cardiology|September 13, 2011
Statins, cholesterol depletion and risk of incident diabetesLuca Mascitelli, Mark R Goldstein
Lancet (London, England)|October 18, 2011
Benefits of lowering cholesterol in chronic kidney diseaseLuca Mascitelli, Mark R Goldstein
International Journal of Cardiology|November 11, 2011
Might diabetes-related increased iron stores erase the female advantage in the development of coronary heart disease?Luca Mascitelli, Mark R Goldstein
JAMA Cardiology|January 5, 2017
Effect of Iron Levels on Women After Premature or Early-Onset MenopauseLuca Mascitelli, Mark R Goldstein
Journal of the American College of Cardiology|January 1, 2016
Evaluating Statin Versus Statin Plus Ezetimibe for Coronary Plaque RegressionLuca Mascitelli, Mark R Goldstein
Pageof 20